Proposed Rules

• Medicare Program: Electronic Prescribing of Controlled Substances; Request for Information (RFI)

  

• Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, and End-Stage Renal Disease Quality Incentive Program

  

• Medicare and Medicaid Programs; CY 2021 Home Health Prospective Payment System Rate Update; Home Health Quality Reporting Requirements; and Home Infusion Therapy Services Requirements

  

• Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements

  

• Amendments to the HHS-Operated Risk Adjustment Data Validation Under the Patient Protection and Affordable Care Act HHS-Operated Risk Adjustment Program

  

• Coordinating Care From Out-of-State Providers for Medicaid-Eligible Children With Medically Complex Conditions; Reopening of Comment Period

  

• Medicare Program: Comprehensive Care for Joint Replacement Model Three-Year Extension and Changes To Episode Definition and Pricing; Extension of Comment Period

  

• Grants, Contracts, And Other Agreements: Fraud and Abuse; Information Blocking; Office of Inspector General Civil Money Penalty Rules

  

• Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2021

  

• Medicaid Program; Preadmission Screening and Resident Review; Extension of Comment Period

  

• Medicare Program; FY 2021 Inpatient Psychiatric Facilities Prospective Payment System (IPF PPS)

  

• Medicare Program; FY 2021 Hospice Wage Index and Payment Rate Update

  

• Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Value-Based Purchasing Program for Federal Fiscal Year 2021

  

• Microbiology Devices; Reclassification of Certain Hepatitis C Virus Antibody Assays Devices, To Be Renamed Hepatitis C Virus Antibody Tests

  

• Microbiology Devices; Reclassification of Nucleic Acid-Based Hepatitis C Virus Ribonucleic Acid Assay Devices, To Be Renamed Nucleic Acid-Based Hepatitis C Virus Ribonucleic Acid Tests

  

• Possession, Use, and Transfer of Select Agents and Toxins; Biennial Review

  

• World Trade Center Health Program; Petition 025-Parkinsons Disease and Parkinsonism, Including Heavy Metal-Induced Parkinsonism; Finding of Insufficient Evidence

  

• Medicaid Program: Preadmission Screening and Resident Review

  

• Medicare Program; Medicare Secondary Payer and Certain Civil Money Penalties

  

• Medicare and Medicaid Programs; Contract Year 2021 and 2022 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicaid Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly